Nuclear Medicine Market to Exhibit a CAGR of 9.0%; Technological Advancements in Nuclear Imaging Methods to Enable Market Growth, Says Fortune Business InsightsHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Nuclear Medicine Market to Exhibit a CAGR of 9.0%; Technological Advancements in Nuclear Imaging Methods to Enable Market Growth, Says Fortune Business InsightsPR NewswireJanuary 7, 2020ReblogShareTweetShareKey Companies Covered in the Radiopharmaceuticals Market Research Report are Lantheus Medical Imaging, Inc., Cardinal Health, Norgine B.V., Curium, Advanced Accelerator Applications (Novartis AG), Bracco Diagnostic Inc., Jubilant Life Sciences Limited, GE Healthcare (General Electric Company) & othersPUNE, India, Jan. 7, 2020 /PRNewswire/ -- The global Nuclear Medicine/ Radiopharmaceuticals Market size is projected to reach USD 9.54 billion by 2026. According to a report published by Fortune Business Insights, titled "Nuclear Medicine/ Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026," the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.0% from 2019-2026.View photosNuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026MoreRadiopharmaceuticals are substances that are used to diagnose specific medical problems or diseases. Increasing imaging capabilities and efficiencies have led to a wide product adoption across the world. Increasing number of successful clinical trials associated with radiopharmaceuticals will fuel the demand for the product. Recent drug application area discoveries have showcased promise for the companies operating in the market. Technological advancements in nuclear imaging and their applications in diagnosis of cancer and other serious diseases have opened up a huge potential for growth. Growing awareness regarding the adverse effects of chronic diseases, and the need for early diagnosis will aid market growth. The advancements in imaging systems have played a major role in the growth of the market. Companies are putting in increased efforts towards the manufacturing of diagnostic radiopharmaceuticals. Increasing investments in the research and development (R&D) will create several growth opportunities for market growth.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812The report offers insights into the global Nuclear Medicine/ Radiopharmaceuticals Market, with primary focus on aspects such as leading product types, major companies, and areas that have witnessed the highest applications. It briefly summarizes the competitive landscape of the market and identifies companies that have potential to dominate the market in the coming years. Additionally, the report encompasses several factors that have contributed to the growth of the market. Based on extensive research analysis methods, the report provides forecast values for the market for the period of 2019-2026.Driven by Increasing Number of Product Launches, Market to Expand at a High RateThe increasing number of product launches has offered a wider scope for growth. The presence of several pipeline drugs will open up a potential for the growth of the market in the coming years. The increased investment has massively helped the development of these pipeline drugs. Increased emphasis on R&D of pipeline drugs has enabled the possibilities to explore the untapped potential that is carried by radiopharmaceuticals. In 2018, Norgine B.V. announced the launch of Lymphoseek, a radiopharmaceutical designed for oncological procedures. The report highlights new products, similar to Lymphoseek and gauges the impact of these products on the market.Story continuesRequest a Sample Copy: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812North America to Witness Highest Growth; Growing Adoption of Nuclear Imaging to Aid GrowthThe report segments the market on the basis of regional demographics into Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The advancements in nuclear imaging has contributed to the growth of the market in North America. Increased awareness regarding the adverse effects of cancer and other serious diseases will create several growth opportunities for the companies operating in the regional market of North America.List of the leading companies that are operating in the global Nuclear Medicine/ Radiopharmaceuticals Market are:Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812Lantheus Medical Imaging, Inc. Cardinal Health Norgine B.V. Curium Advanced Accelerator Applications (Novartis AG) Bracco Diagnostic Inc. Jubilant Life Sciences Limited GE Healthcare (General Electric Company)Detailed Table of Content:Introduction Executive Summary Market Dynamics Key Insights Global Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026 TOC Continued….!Request for Customization:  https://www.fortunebusinessinsights.com/enquiry/customization/nuclear-medicine-radiopharmaceuticals-market-101812Have a Look at Related Reports:Radiation Dose Management Market Size, Share and Global Trend By Type (Software, Service), By Imaging Modality (Radiography, Tomography, Nuclear Imaging, Interventional Imaging), By Application (Cardiology, Neurology, Oncology, Orthopaedics), By End-User (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers) and Geography Forecast till 2026Radiation Therapy Market Size, Share and Global Trend By Type (External Beam Radiation Therapy, Internal Radiation therapy (brachytherapy), Others), By End Users (Hospitals & Diagnostic Laboratories, Cancer Treatment & Research Centers, Academic Research Organizations, Others) and Geography Forecast till 2026Medical Radiation Shielding Market Size, Share and Global Trend By Imaging Equipment (X-Ray, Magnetic Resonance Imaging (MRI),Computed Tomography, Ultrasound, Others), By Product (Building Materials (Sheet Lead, Bricks, Curtain, and Others), Wearables, Others), By End User (Hospitals, Diagnostic Centres, Cancer Centres, Biopharmaceutical Companies, Others) and Geography Forecast till 2026Non-ionizing Radiation Market Size, Share and Global Trend By Radiation Type (Radiofrequency, Microwaves, Infrared, UV rays, Visible light), By Application (Diagnostics, Cosmetics, Others), By End User (Hospitals, Clinics, Research Organizations, Diagnostic Centers) and Geography Forecast till 2026Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases and Bacterial Diseases), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2019-2026Guidewire Market Size, Share & Industry Analysis, By Product (Coronary Guidewire, Peripheral Guidewire, Urology Guidewire, Neurovascular Guidewire, and Others) By Material (Nitinol, Stainless Steel, and Others) By Coating (Coated and Non-Coated) By End User (Hospitals & Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2026About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:Fortune Business Insights™ Pvt. Ltd.308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.Phone:US :+1-424-253-0390UK : +44-2071-939123APAC : +91-744-740-1245Email: sales@fortunebusinessinsights.comWebsite: https://www.fortunebusinessinsights.comLinkedIn | Twitter | Blogs View photosFortune Business Insights Logo (PRNewsfoto/Fortune Business Insights)MoreCisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/nuclear-medicine-market-to-exhibit-a-cagr-of-9-0-technological-advancements-in-nuclear-imaging-methods-to-enable-market-growth-says-fortune-business-insights-300982466.htmlSOURCE Fortune Business InsightsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextFragile Economic Recovery in India Faces New Risk from VirusBloombergCitigroup, Goldman, JPMorgan Slash Earnings Estimates for StocksBloombergHow investors are using ‘alternative’ data to track China’s recovery from coronaviruMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoShould You Buy Antevenio, S.A. (EPA:ALANT) For Its Dividend?Simply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoHere's What Absolent Group AB (publ)'s (STO:ABSO) P/E Is Telling UsSimply Wall St.Stock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance